OTC rs66521141: Understanding This Rare Genetic Variant
The rs66521141 variant is a rare genetic change located within the OTC gene, which provides instructions for an enzyme critical to the body's urea cycle. This variant has been associated with ornithine transcarbamylase deficiency, a condition that can lead to the accumulation of toxic ammonia in the blood.
What each genotype means
Typical ornithine transcarbamylase genotype
This genotype represents the most common allele configuration observed in general population studies for this position. It is generally not considered to be associated with ornithine transcarbamylase deficiency.
This is the most common genotype observed across major global populations.
Potential carrier status
Carrying one copy of this variant may be associated with carrier status for ornithine transcarbamylase deficiency, an X-linked condition. Because the evidence is limited, the clinical significance of this specific genotype remains unclear; please discuss this result with a genetic counselor or your clinician to understand its context in your health history.
This genotype is rare in the general population, with specific frequencies varying by ancestry.
Rare variant genotype
This genotype indicates the presence of two copies of the variant, which is extremely rare in the general population. While the variant is categorized as being associated with ornithine transcarbamylase deficiency, the functional impact of this homozygous state is not well-characterized in current research. You should consult with a medical geneticist or specialist to interpret this finding in the context of your personal health.
This genotype is exceptionally rare and is not frequently observed in large-scale population databases.
What is rs66521141 and Where is it Located?
The variant rs66521141 is a single nucleotide polymorphism (SNP) situated on the X chromosome at position 38,367,367 (GRCh38). Because it is located on the X chromosome, the inheritance pattern of this variant is X-linked. This means that males, who typically have only one X chromosome, are more directly affected by variants in this gene than females, who have two X chromosomes. In the context of genetic testing, this variant represents a specific change in the DNA sequence of the OTC gene. Understanding its location is essential for clinicians and geneticists when interpreting how a person's genetic makeup might influence their metabolic health, particularly regarding the processing of nitrogenous waste products in the liver.
The Role of the OTC Gene
The OTC gene encodes the enzyme ornithine transcarbamylase, which is a vital component of the urea cycle. The urea cycle is a series of biochemical reactions occurring primarily in the liver that converts excess nitrogen—a byproduct of protein metabolism—into urea, which is then safely excreted by the kidneys. When the OTC enzyme is absent or not functioning correctly, the urea cycle is disrupted, leading to the buildup of ammonia in the bloodstream. Ammonia is highly toxic, especially to the central nervous system. Consequently, individuals with significant dysfunction in this enzyme may experience neurological symptoms, lethargy, or other metabolic complications. The severity of these symptoms often depends on the level of residual enzyme activity.
Research and Clinical Evidence
Research associates the rs66521141 variant with ornithine transcarbamylase deficiency (OTCD). Clinical databases, including ClinVar, have categorized certain changes at this position as pathogenic. However, it is important to note that the evidence strength for this specific variant is considered limited in some contexts. While mutations in the OTC gene are the primary cause of OTCD, the clinical presentation can vary widely, ranging from severe neonatal-onset disease to milder, late-onset forms. Because the condition is X-linked, females may show a range of symptoms depending on the process of X-inactivation, where one X chromosome is silenced in each cell. Genetic findings should always be interpreted by a qualified medical professional who can correlate the molecular data with clinical symptoms and biochemical testing.
Population Frequency and Interpretation
The rs66521141 variant is classified as rare in the general population. Because it is a rare variant, it is not typically found in the majority of individuals. When interpreting genetic reports, it is crucial to distinguish between being a carrier and having a clinical diagnosis. A carrier may have one altered copy of the gene but might not exhibit the full spectrum of symptoms associated with the deficiency. Conversely, because of the X-linked nature of the gene, males with a single altered copy are more likely to be affected. If you have received a report indicating the presence of this variant, it is recommended to consult with a genetic counselor or a metabolic specialist. They can provide context based on your personal and family medical history.
What You Can and Cannot Do With This Information
Genetic information regarding the OTC gene is highly specialized and should not be used for self-diagnosis. If you are concerned about your results, you cannot use this information to make medical decisions, such as altering your diet or starting supplements, without direct supervision from a healthcare provider. What you can do is use this information to facilitate a productive conversation with your doctor. Bring your genetic report to a clinical geneticist or a metabolic specialist who can order appropriate biochemical tests, such as plasma ammonia or amino acid levels, to assess your current metabolic status. Remember that a genetic variant is only one piece of the puzzle; clinical evaluation and laboratory testing are necessary to determine if the variant is having a functional impact on your health.
How common is this variant?
The rs66521141 variant is considered rare across all major population groups.
Frequently asked questions
What is ornithine transcarbamylase deficiency?
It is a genetic disorder that prevents the body from properly processing nitrogen, leading to a buildup of toxic ammonia in the blood. This can cause neurological issues and requires medical management.
Is rs66521141 always harmful?
Genetic variants can have varying effects. While this variant is associated with a known deficiency, clinical outcomes depend on many factors, including the specific nature of the mutation and individual biology.
Should I be worried if I have this variant?
Finding a rare variant does not automatically mean you have a disease. You should discuss the result with a genetic counselor or a metabolic specialist to understand its clinical significance for you.
How is this condition inherited?
It is inherited in an X-linked manner. This means the gene is located on the X chromosome, which affects how it is passed from parents to children and how it manifests in males versus females.
Sources & further reading
Educational information only, last refreshed 9/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs66521141?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in OTC
Pathogenic variant predisposing to acute hyperammonemic crisis triggered by metabolic stressors.
This variant is associated with ornithine transcarbamylase (OTC) deficiency, a rare urea cycle disorder that can lead to dangerous ammonia accumulation.